Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine
3 November 2021
| COVID-19: Vaccines
Overview
This background document on the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19 was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) on Immunization to inform SAGE deliberations. It contains the evidence summary which was considered by SAGE and served as the foundation for the WHO Interim recommendations referenced below.
This background document was
developed to inform the initial recommendation-making process. It is not
updated on a regular basis. For the latest Grade and ETR tables see
link below.
WHO Team
Agenda, Policy & Strategy (APS),
Immunization, Vaccines and Biologicals (IVB),
Strategic Advisory Group of Experts on Immunization,
WHO Headquarters (HQ)
Number of pages
22
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/BBV152/background/2021.1